Bluerock Sourcing Solutions company information, Employees & Contact Information

Bluerock Interval fund wins shareholder approval to start trading. InvestmentNews

How Bluerock Homes Trust Inc. stock trades during market volatility - 2025 Market Overview & Weekly High Return Stock Forecasts Trung tâm Dự báo KTTV quốc gia

Bluerock Value Exchange Launches $71 Million 1031 Exchange BR Diversified Industrial Portfolio 6 DST PR Newswire

Bayer-owned BlueRock lays off 50 employees, shutters Cambridge research labs Fierce Biotech

BlueRock TMS Expands North American Leadership with Appointment of Brent Wallace GlobeNewswire

Bluerock Total Income+ Real Estate Fund Celebrates its 50th Consecutive Quarterly Distribution Yahoo Finance

BlueRock accelerates Parkinson’s disease therapy to Phase III Clinical Trials Arena

Bluerock Homes Trust: Encouraging Developments (Rating Upgrade) (NYSE:BHM) Seeking Alpha

BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial Bayer

Aug Breakouts: Will Bluerock Homes Trust Inc. Class stock attract long term capital inflows - Weekly Trend Report & Daily Risk Controlled Trade Plans Trung tâm Dự báo KTTV quốc gia

Bluerock seeks to list real estate fund with investors already heading for the exits. InvestmentNews

Bluerock Value Exchange Fully Subscribes $36.7 Million Diversified Industrial Portfolio V DST PR Newswire

BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease GlobeNewswire

Bluerock interval fund could trade at “substantial discount” after it lists, company says. InvestmentNews

BlueRock Begins First Human Trial of iPSC Cell Therapy for Primary Photoreceptor Diseases Applied Clinical Trials

Financial services firm BlueRock facing $3m in directors’ dismissal claims AFR

Bluerock Pays $103M for Tampa Community Multi-Housing News

Made in Idaho: BlueRock Farm Market KIVI-TV

BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies Bayer

FDA approves BlueRock’s cell therapy IND for photoreceptor diseases trial Clinical Trials Arena

BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for treating Primary Photoreceptor Diseases from FUJIFILM Cellular Dynamics and Opsis Therapeutics BioInformant

First Parkinson’s disease patient treated in BlueRock’s GlobeNewswire

36-Month Phase I: BlueRock’s bemdaneprocel Shows Durable Safety and Motor Improvements Stock Titan

Blackstone Will Buy Bluerock Residential in $3.6bn Deal Private Equity Insights

Bluerock Total Income+ Real Estate Fund Secures $750 Million Line of Credit with JPMorgan, RBC Capital Markets PR Newswire

Bluerock sets its sights on Rockingham businessnews.com.au

BlueRock Consulting launches the Luxury Hotel Benchmarking Report Hospitality Net

Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts Fierce Biotech

Bluerock Value Exchange Launches $37.8 Million 1031 Exchange BR Churchill Downs Multifamily DST in Pinehurst, NC PR Newswire

BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial PR Newswire

Bayer subsidiary BlueRock taps Rune Labs for Parkinson's study software Fierce Biotech

Bluerock Appoints Doug Kinney as Managing Director citybiz

Bluerock Homes Trust Completes Acquisition of Skytop Apartments TipRanks

Bayer christens $250M cell therapy 'launch facility' in Berkeley Fierce Pharma

Fujifilm Cellular Dynamics, Opsis Therapeutics and BlueRock Therapeutics Form Agreement Contract Pharma

Fraggle Rock: 40 Years Later – “The Beast of Bluerock” ToughPigs

Blackstone concludes $3.6 billion acquisition of Bluerock Mortgage Professional America

Blackstone affiliates to buy Bluerock REIT in $3.6 bln deal Reuters

Fortino Capital makes strategic investment in BlueRock TMS to help boost its international growth ambitions American Journal of Transportation

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy PR Newswire

Bluerock buys second Lane Industrial Park building in Northwest Jacksonville Jacksonville Daily Record

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases PR Newswire

Will Bluerock Homes Trust Inc. Class stock attract long term capital inflows - July 2025 Chart Watch & High Accuracy Trade Signal Alerts Trung tâm Dự báo KTTV quốc gia

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy PMLiVE

Bayer to pay $240M to buy BlueRock cell therapy joint venture Fierce Biotech

Already Owning 40.8% of BlueRock Therapeutics, Bayer Buys Rest of Company for $600 Million BioSpace

BlueRock acquires specialist music & entertainment advisory White Sky Consultancy.com.au

Dutch company BlueRock TMS onboards Fortino Capital as an investor: Here’s why Silicon Canals

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes Business Wire

Bayer buys BlueRock in $600 million bet on stem cell therapies Reuters

Blackstone Buying Multifamily REIT Bluerock for $3.6B The Real Deal

BlueRock Horizon Asset Management: Marcus Erikson Unveils Tech-Driven Strategy ACCESS Newswire

This startup wants to regenerate the heart and brain to keep people healthier for longer businessinsider.com

BlueRock adds Arthur Advisory as it pursues capital partner Consultancy.com.au

BlueRock adds directors to R&D and government incentives team Consultancy.com.au

Ophir hops onto BlueRock’s register; expands into unlisted markets AFR

BlueRock appoints Ella Morse, Trevor Gordijn and Bevan McLeod Consultancy.com.au

Bluerock Projects receives DA for Rockingham BTR BTR News Australia

Works at Bluerock Projects’ Tuohy Garden Apartments progressing BTR News Australia

Pharmaceutical company Bayer AG acquiring BlueRock Therapeutics for US$1-billion The Globe and Mail